how many people use glp-1 drugs trends 2025: real-world data, patient outcomes & future therapies Insights from Specialty Physicians on
Description
Semaglutide is massively popular
Beneficiaries are encouraged to consult with their physicians to determine whether a GLP-1 medication is suitable for their individual health needs
Importantly, most subjects with exenatide-induced volume contraction were receiving drugs that inhibit the renin-angiotensin system and aldosterone formation
Oral semaglutide led to similar weight loss as injection, company says
Exenatide extended-release (Bydureon/BCise) carries a boxed warning regarding thyroid C-cell tumors based on rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
